Immunotec Announces Completion of its International Convention in Mexico City
26 February 2014 - 8:05AM
Marketwired
Immunotec Announces Completion of its International Convention in
Mexico City
1,500 Consultants celebrating Culture and Field
Accomplishments.
VAUDREUIL-DORION, QUEBEC--(Marketwired - Feb 25, 2014) -
Immunotec Inc. (TSX-VENTURE:IMM), a Canadian based company and a
leader in the wellness industry (the "Company") today announces the
completion of its International Convention held from February 20 to
22, 2014 at the Expo Bancomer Convention Center in Santa Fe,
Mexico. Under the theme One Vision, One Team,
nearly 1,500 independent Consultants participated in celebrating
the Immunotec heritage of developing innovative products while
being recognized for their accomplishments over the past year.
"This event was a success surpassing previous Convention
attendee counts and a testimony of our performance in Mexico," said
Mr. Charles L. Orr, Chief Executive Officer." This platform also
launched our new plans for 2014. The new programs are designed to
support our Field in achieving future growth as we are preparing to
leverage the content and excitement of this Convention on a road
tour in many cities starting March 15th in Montreal, Toronto,
Orlando, Los Angeles and more to come."
"Many of our independent Consultants experienced growth in
building their businesses during 2013. This has enabled them to
advance in rank while developing their businesses across our
network and markets," said JP Trottier, Immunotec's Vice-President
of Business Development. "The 2014 Trip Incentive this coming
November was launched and everybody committed to reach new heights
and qualify to attend."
About Immunotec Inc.
Immunotec Inc. is dedicated to making a positive difference in
people's lifestyle every day by offering research-driven
nutritional products through its network of Independent Consultants
worldwide. Immunotec's strength comes from its culture that
emphasizes teamwork and entrepreneurial leadership by employees,
consultants and research collaborators.
Headquartered with manufacturing facilities near Montreal,
Canada, Immunotec Consultants generate nearly $55.0 Million in
annual revenues. Please visit us at www.immunotec.com for
additional information.
The Company files its consolidated financial statements, its
management and discussion analysis report, its press releases and
such other required documents on the SEDAR database at
www.sedar.com and on the Company's website at www.immunotec.com.
The common shares of the Company are listed on the TSX Venture
Exchange under the ticker symbol IMM. Neither TSX Venture Exchange
nor its Regulation Services Provider (as that term is defined in
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain
statements contained in this news release are forward looking and
are subject to numerous risks and uncertainties, known and unknown.
For information identifying known risks and uncertainties and other
important factors that could cause actual results to differ
materially from those anticipated in the forward-looking
statements, please refer to the heading Risks and Uncertainties in
Immunotec's most recent Management's Discussion and Analysis, which
can be found at www.sedar.com. Consequently, actual results may
differ materially from the anticipated results expressed in these
forward-looking statements.
Patrick Montpetit CPA, CA, CFVice-President and Chief Financial
OfficerImmunotec Inc.(450) 510-4527
International Metals Min... (TSXV:IMM)
Historical Stock Chart
From Apr 2024 to May 2024
International Metals Min... (TSXV:IMM)
Historical Stock Chart
From May 2023 to May 2024
